Showing results (41-50 of 345) with videos related to
Sort By:
Pageof 35
Molecular Pharmacology|December 19, 2002
Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanismsShujie Wang, Zhiliang Wang, Steven GrantMolecular Pharmacology|December 4, 2003
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xLYun Dai, Paul Dent, Steven GrantFrontiers in Bioscience : a Journal and Virtual Library|January 30, 2002
Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survivalSteven Grant, Liang Qiao, Paul DentCell Cycle (Georgetown, Tex.)|November 14, 2002
Induction of apoptosis in human leukemia cells by the CDK1 inhibitor CGP74514AYun Dai, Paul Dent, Steven GrantCell Cycle (Georgetown, Tex.)|September 10, 2003
An intact NF-kappaB pathway is required for histone deacetylase inhibitor-induced G1 arrest and maturation in U937 human myeloid leukemia cellsYun Dai, Mohamed Rahmani, Steven GrantPharmacology & Therapeutics|April 29, 2014
Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insightsPrithviraj Bose, Yun Dai, Steven GrantTexas Heart Institute Journal|May 14, 2009
Endovascular repair of injury to a persistent sciatic arteryFritz J Baumgartner, Anthony Kalinowski, Steven GrantExpert Opinion on Investigational Drugs|May 8, 2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary L Simmons, Steven GrantMolecular Cancer Therapeutics|January 7, 2005
The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanismXin-Yan Pei, Yun Dai, Steven GrantClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitorsXin-Yan Pei, Yun Dai, Steven GrantPageof 35